Cue Biopharma, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cue Biopharma, Inc., a Delaware corporation and emerging growth company, on December 27, 2017. The report details the completion of the Company's initial public offering (IPO) and amendments to its corporate charter.
Key Financial Metrics
- Gross Proceeds: $66,155,325 generated from the sale of 8,820,710 shares of Common Stock.
- Offering Price: $7.50 per share.
- Underwriter Warrants: 882,071 warrants issued to underwriters with an exercise price of $9.375 per share.
- Trading Symbol: "CUE" on the Nasdaq Capital Market (expected start date: January 2, 2018).
- Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity, as this report focuses on the capital event rather than operational performance.
Material Changes
The primary material change is the transition from a private to a public company via the completion of the IPO on December 27, 2017. Additionally, on December 21, 2017, the Company amended and restated its Certificate of Incorporation in connection with the Offering.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the Offering and the incorporation of the Amended and Restated Charter by reference to the Form S-1 filed on December 13, 2017. The filing does not contain specific forward-looking guidance, risk factors, or contingencies within this document; investors are directed to the S-1 for detailed descriptions of the capital stock and underwriting terms.
Key Facts for Investor Verification
- Verify the final net proceeds after deducting underwriting commissions and offering expenses, as only gross proceeds are listed here.
- Review the full text of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) for details on capital structure and governance.
- Confirm the terms of the underwriter's warrants, including expiration and exercise conditions, as described in the referenced Form S-1.
- Check the Form S-1 for comprehensive risk factors and financial statements not included in this 8-K.